Toll-like receptor 4–deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension

REFERENCES

• Frantz S, Ertl G, Bauersachs J: Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2007;4:444–454.
   PubMedGoogle Scholar
• Hashimoto C, Hudson KL, Anderson KV: The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell. 1988;52:269–279.
   PubMed Web of Science ®Google Scholar
• Kaczorowski DJ, Mollen KP, Edmonds R, Billiar TR: Early events in the recognition of danger signals after tissue injury. J Leukoc Biol. 2008;83:546–552.
   PubMed Web of Science ®Google Scholar
• Li H, Sun B: Toll-like receptor 4 in atherosclerosis. J Cell Mol Med. 2007;11:88–95.
   PubMed Web of Science ®Google Scholar
• Becker MN, Diamond G, Verghese MW, Randell SH: CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem. 2000;275:29731–29736.
   PubMed Web of Science ®Google Scholar
• Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M: Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol. 2001;166:2018–2024.
   PubMed Web of Science ®Google Scholar
• Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, Luthringer D, Xu XP, Rajavashisth TB, Yano J, Kaul S, Arditi M: Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation. 2001;104:3103–3108.
   PubMed Web of Science ®Google Scholar
• Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085–2088.
   PubMed Web of Science ®Google Scholar
• Poltorak A, Smirnova I, He X, Liu MY, Van Huffel C, McNally O, Birdwell D, Alejos E, Silva M, Du X, Thompson P, Chan EK, Ledesma J, Roe B, Clifton S, Vogel SN, Beutler B: Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis. 1998;24:340–355.
   PubMed Web of Science ®Google Scholar
• Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, Wagner H: Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem. 2001;276:31332–31339.
   PubMed Web of Science ®Google Scholar
• Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF 3rd: The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem. 2001;276:10229–10233.
   PubMed Web of Science ®Google Scholar
• Smiley ST, King JA, Hancock WW: Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol. 2001;167:2887–2894.
   PubMed Web of Science ®Google Scholar
• Watari M, Watari H, Nachamkin I, Strauss JF: Lipopolysaccharide induces expression of genes encoding pro-inflammatory cytokines and the elastin-degrading enzyme, cathepsin S, in human cervical smooth-muscle cells. J Soc Gynecol Investig. 2000;7:190–198.
   PubMedGoogle Scholar
• Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675–680.
   PubMed Web of Science ®Google Scholar
• Kaisho T, Akira S: Toll-like receptors and their signaling mechanism in innate immunity. Acta Odontol Scand. 2001;59:124–130.
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Dinarello CA: The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol Today. 2000;21:206–209.
   PubMedGoogle Scholar
• Durmowicz AG, Parks WC, Hyde DM, Mecham RP, Stenmark KR: Persistence, re-expression, and induction of pulmonary arterial fibronectin, tropoelastin, and type I procollagen mRNA expression in neonatal hypoxic pulmonary hypertension. Am J Pathol. 1994;145:1411–1420.
   PubMed Web of Science ®Google Scholar
• Laudi S, Steudel W, Jonscher K, Schoning W, Schniedewind B, Kaisers U, Christians U, Trump S: Comparison of lung proteome profiles in two rodent models of pulmonary arterial hypertension. Proteomics. 2007;7:2469–2478.
   PubMed Web of Science ®Google Scholar
• Madjdpour C, Jewell UR, Kneller S, Ziegler U, Schwendener R, Booy C, Klausli L, Pasch T, Schimmer RC, Beck-Schimmer B: Decreased alveolar oxygen induces lung inflammation. Am J Physiol Lung Cell Mol Physiol. 2003;284:L360-L367.
   PubMed Web of Science ®Google Scholar
• Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, Kourembanas S: Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A. 2001;98:8798–8803.
   PubMed Web of Science ®Google Scholar
• Stenmark KR, Davie NJ, Reeves JT, Frid MG: Hypoxia, leukocytes, and the pulmonary circulation. J Appl Physiol. 2005;98:715–721.
   PubMed Web of Science ®Google Scholar
• Korshunov VA, Berk BC: Strain-dependent vascular remodeling: the “Glagov phenomenon” is genetically determined. Circulation. 2004;110:220–226.
   PubMed Web of Science ®Google Scholar
• Pelus LM, Bian H, King AG, Fukuda S: Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROβ/CXCL2 and GROβT /CXCL2Δ4. Blood. 2004;103:110–119.
   PubMed Web of Science ®Google Scholar
• Rabinovitch M: Pathobiology of pulmonary hypertension. Extracellular matrix. Clin Chest Med. 2001;22:433–449.
   PubMed Web of Science ®Google Scholar
• Bull TM, Coldren CD, Moore M, Sotto-Santiago SM, Pham DV, Nana-Sinkam SP, Voelkel NF, Geraci MW: Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2004;170:911–919.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri B, Bonfield TL, Malur A, Hague K, Kavuru MS, Arroliga AC, Thomassen MJ: Circulating monocytes from patients with primary pulmonary hypertension are hyporesponsive. Clin Immunol. 2002;104:191–198.
   PubMed Web of Science ®Google Scholar
• Michelsen KS, Doherty TM, Shah PK, Arditi M: TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol. 2004;173:5901–5907.
   PubMed Web of Science ®Google Scholar
• Michelsen KS, Doherty TM, Shah PK, Arditi M: Role of Toll-like receptors in atherosclerosis. Circ Res. 2004:95:e96-e97.
   PubMed Web of Science ®Google Scholar
• Stoll LL, Denning GM, Li WG, Rice JB, Harrelson AL, Romig SA, Gunnlaugsson ST, Miller FJ Jr, Weintraub NL: Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J Immunol. 2004;173:1336–1343.
   PubMed Web of Science ®Google Scholar
• Vink A, Schoneveld AH, Van Der Meer JJ, van Middelaar BJ, Sluijter JP, Smeets MB, Quax PH, Lim SK, Borst C, Pasterkamp G, de Kleijn DP: In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation. 2002;106:1985–1990.
   PubMed Web of Science ®Google Scholar
• Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, Doevendans PA, van Echteld CJ, Joles JA, Quax PH, Piek JJ, Pasterkamp G, de Kleijn DP: Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res. 2008;102:257–264.
   PubMed Web of Science ®Google Scholar
• Ha T, Li Y, Hua F, Ma J, Gao X, Kelley J, Zhao A, Haddad GE, Williams DL, William Browder I, Kao RL, Li C: Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload. Cardiovasc Res. 2005;68:224–234.
   PubMed Web of Science ®Google Scholar
• Oyama J, Blais C, Jr., Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T: Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation. 2004;109:784–789.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Tasaka S, Yamada W, Saito F, Hasegawa N, Miyasho T, Ishizaka A: Role of Toll-like receptor 4 in hyperoxia-induced lung inflammation in mice. Inflamm Res. 2007;56:334–338.
   PubMed Web of Science ®Google Scholar
• Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M: Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A. 2004;101:10679–10684.
   PubMed Web of Science ®Google Scholar
• Smith RM, McCarthy J, Sack MN: TNF alpha is required for hypoxia-mediated right ventricular hypertrophy. Mol Cell Biochem. 2001;219:139–143.
   PubMed Web of Science ®Google Scholar
• Fujita M, Shannon JM, Irvin CG, Fagan KA, Cool C, Augustin A, Mason RJ: Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2001;280:L39-L49.
   PubMed Web of Science ®Google Scholar
• Ito T, Okada T, Miyashita H, Nomoto T, Nonaka-Sarukawa M, Uchibori R, Maeda Y, Urabe M, Mizukami H, Kume A, Takahashi M, Ikeda U, Shimada K, Ozawa K: Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats. Circ Res. 2007;101:734–741.
   PubMed Web of Science ®Google Scholar
• Grenier D, Grignon L: Response of human macrophage-like cells to stimulation by Fusobacterium nucleatum ssp. nucleatum lipopolysaccharide. Oral Microbiol Immunol. 2006;21:190–196.
   PubMedGoogle Scholar
• Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90:251–262.
   PubMed Web of Science ®Google Scholar
• Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P: Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181–189.
   PubMed Web of Science ®Google Scholar
• Russell REK, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, Fitzgerald M, Barnes PJ: Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol. 2002;283:L867-L873.
   PubMed Web of Science ®Google Scholar
• Herget J, Novotna J, Bibova J, Povysilova V, Vankova M, Hampl V: Metalloproteinase inhibition by Batimastat attenuates pulmonary hypertension in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol. 2003;285:L199-L208.
   PubMed Web of Science ®Google Scholar
• Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V: Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol. 2007;178:7516–7519.
   PubMed Web of Science ®Google Scholar
• Pugh CW, Ratcliffe PJ: Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9:677–684.
   PubMed Web of Science ®Google Scholar
• Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, Semenza GL: Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest. 1999;103:691–696.
   PubMed Web of Science ®Google Scholar